1st Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety issues; Monitor drug pricing legislation; H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Issues related to reauthorization of FDA user fee bills including accelerated approval; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; Consolidated Appropriations Act, 2022 (PL 117-103)

LobbyistCovered position, as disclosed
TRACY SPICER —

Bills named: H.R. 5585 (117th), H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

S. 1435, Affordable Prescriptions for Patients Act of 2021

LobbyistCovered position, as disclosed
TRACY SPICER —

Bills named: S. 1435 (117th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.